Publikationen in Zusammenarbeit mit Forschern von Medical University of Vienna (32)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2022

  1. Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?

    Clinical Reviews in Allergy and Immunology, Vol. 62, Núm. 1

  2. Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?

    Clinical Reviews in Allergy and Immunology, Vol. 62, Núm. 1, pp. 37-63

2021

  1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

    Clinical and Translational Allergy, Vol. 11, Núm. 4

  2. Allergens and their associated small molecule ligands—their dual role in sensitization

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2367-2382

  3. Biologicals in atopic disease in pregnancy: An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 71-89

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie

    Allergologie, Vol. 43, Núm. 7, pp. 255-271

  2. Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot

    Biology, Vol. 9, Núm. 3

  3. EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network

    Allergy: European Journal of Allergy and Clinical Immunology

  4. In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 9, pp. 2161-2169

  5. Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 11, pp. 2064-2076

2018

  1. Peanut lipids display potential adjuvanticity by triggering a pro-inflammatory response in human keratinocytes

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

    Allergo Journal International, Vol. 27, Núm. 8, pp. 245-255

2017

  1. Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

    Oncotarget, Vol. 8, Núm. 7, pp. 11600-11613

2016

  1. Epitope specificity determines cross-protection of a SIT-induced IgG4 antibody

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 71, Núm. 1, pp. 36-46

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  4. The lipid interaction capacity of Sin a 2 and Ara h 1, major mustard and peanut allergens of the cupin superfamily, endorses allergenicity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 71, Núm. 9, pp. 1284-1294